UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience

Biology (Basel, Switzerland), 2022-02, Vol.11 (2), p.247

2022

Volltextzugriff (PDF)

Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature

Clinical Pediatric Hematology-Oncology, 2022, 29(1), , pp.12-16

2022

Volltextzugriff (PDF)

PB2541: RARE CAP +41 TO +44 [HBB:C.11_‐8DELAAAC]/NI MUTATION IN THE 5;UTR OF THE Β GLOBIN GENE IN A GREEK MALE AND GENETIC COUNSELING

HemaSphere, 2023-08, Vol.7 (S3), p.e22018fd-n/a

2023

Volltextzugriff (PDF)

P1504: HEMATOLOGICAL IMPLICATIONS IN ADOLESCENT GREEK ROMA PREGNANTS

HemaSphere, 2023-08, Vol.7 (S3), p.e6436019-n/a

2023

Volltextzugriff (PDF)

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT ‐THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER

HemaSphere, 2023-04, Vol.7 (S1), p.47-47

2023

Volltextzugriff (PDF)

P1607: QUALITATIVE PLATELET ABNORMALITIES AND MENORRHAGIA IN ADOLESCENTS AND WOMEN OF REPRODUCTIVE AGE. TEN‐YEAR REFERRALS IN A TERTIARY HOSPITAL OF NORTHERN GREECE

HemaSphere, 2023-08, Vol.7 (S3), p.e5078182-n/a

2023

Volltextzugriff (PDF)

P116: THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER

HemaSphere, 2022-01, Vol.6 (Suppl), p.25-25

2022

Volltextzugriff (PDF)

Retrospective Evaluation of Oral Glucose Tolerance Test (OGTT) in Young Patients with Transfusion-Dependent Beta-Thalassemia

Acta haematologica, 2022-03

2022

Volltextzugriff (PDF)

Treatment Individualization Using Pharmacokinetic Studies and Joint Ultrasound Imaging in Pediatric Patients With Hemophilia

Journal of pediatric hematology/oncology, 2022-07, Vol.44 (5), p.237-242

2022

Volltextzugriff (PDF)

A New Hemoglobin Variant, Hb Natal ( HBA1 : c.423C>A), Found in a Greek Family

Hemoglobin, 2022-03, Vol.46 (2), p.132-136

2022

Volltextzugriff (PDF)

Unmasking hypertension in children and adolescents with sickle/beta‐thalassemia

The journal of clinical hypertension (Greenwich, Conn.), 2020-08, Vol.22 (8), p.1444-1449

2020

Volltextzugriff (PDF)

Rare Pathogenic β0-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece

Hemoglobin, 2022-03, Vol.46 (2), p.140-142

2022

Volltextzugriff (PDF)

Rare Pathogenic β 0 -Thalassemia Mutation, Codon 7 ( G AG> T AG) ( HBB : c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece

Hemoglobin, 2022-03, Vol.46 (2), p.140-142

2022

Volltextzugriff (PDF)

Neurological Involvement in a Thalassemic Child Receiving Deferiprone

Journal of pediatric hematology/oncology, 2016-07, Vol.38 (5), p.406-406

2016

Volltextzugriff (PDF)

Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants

Hemoglobin, 2018-07, Vol.42 (4), p.257-263

2018

Volltextzugriff (PDF)

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

Acta haematologica, 2010-01, Vol.123 (3), p.148-152

2010

Volltextzugriff (PDF)

Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α 3.7 /αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling

Hemoglobin, 2018-03, Vol.42 (2), p.129-131

2018

Volltextzugriff (PDF)

Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α3.7/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling

Hemoglobin, 2018-03, Vol.42 (2), p.129-131

2018

Volltextzugriff (PDF)

Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience

Annals of hematology, 2013-01, Vol.92 (2), p.263-265

2013

Volltextzugriff (PDF)

Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin

Blood coagulation & fibrinolysis, 2012-04, Vol.23 (3), p.195-202

2012

Volltextzugriff (PDF)

No Correlation Between Myocardial T2 and Right Ventricular Function in Thalassemia Major. A Single Centre Four Years Experience

Blood, 2011-11, Vol.118 (21), p.5308-5308

2011

Volltextzugriff (PDF)

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

Blood, 2011-11, Vol.118 (21), p.5306-5306

2011

Volltextzugriff (PDF)

Absence of Relationship of Myocardial T2 to Right Ventricular Function In Thalassaemia Major

Blood, 2010-11, Vol.116 (21), p.5160-5160

2010

Volltextzugriff (PDF)

MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

Journal of pediatric hematology/oncology, 2012-08, Vol.34 (6), p.412-415

2012

Volltextzugriff (PDF)

Cross-sectional study of pulmonary function and MRI-derived liver and myocardial iron content in young patients with β-thalassemia major

European journal of haematology, 2011-09, Vol.87 (3), p.279-280

2011

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(27)
Berichte
(2)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience

Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature

PB2541: RARE CAP +41 TO +44 [HBB:C.11_‐8DELAAAC]/NI MUTATION IN THE 5;UTR OF THE Β GLOBIN GENE IN A GREEK MALE AND GENETIC COUNSELING

P1504: HEMATOLOGICAL IMPLICATIONS IN ADOLESCENT GREEK ROMA PREGNANTS

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT ‐THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER

P1607: QUALITATIVE PLATELET ABNORMALITIES AND MENORRHAGIA IN ADOLESCENTS AND WOMEN OF REPRODUCTIVE AGE. TEN‐YEAR REFERRALS IN A TERTIARY HOSPITAL OF NORTHERN GREECE

P116: THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER

Retrospective Evaluation of Oral Glucose Tolerance Test (OGTT) in Young Patients with Transfusion-Dependent Beta-Thalassemia

Treatment Individualization Using Pharmacokinetic Studies and Joint Ultrasound Imaging in Pediatric Patients With Hemophilia

A New Hemoglobin Variant, Hb Natal ( HBA1 : c.423C>A), Found in a Greek Family

Unmasking hypertension in children and adolescents with sickle/beta‐thalassemia

Rare Pathogenic β0-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece

Rare Pathogenic β 0 -Thalassemia Mutation, Codon 7 ( G AG> T AG) ( HBB : c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece

Neurological Involvement in a Thalassemic Child Receiving Deferiprone

Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α 3.7 /αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling

Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α3.7/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling

Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience

Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin

No Correlation Between Myocardial T2 and Right Ventricular Function in Thalassemia Major. A Single Centre Four Years Experience

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

Absence of Relationship of Myocardial T2 to Right Ventricular Function In Thalassaemia Major

MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

Cross-sectional study of pulmonary function and MRI-derived liver and myocardial iron content in young patients with β-thalassemia major

Suchergebnisse filtern